Osaic Holdings
VKTX icon

Osaic Holdings’s Viking Therapeutics VKTX Stock Holding History

Osaic Holdings’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-8
Closed -$1.75K – 8203
2025
Q3 		$1.75K Buy
8
+3
+60% +$89 ﹤0.01% 7172
2025
Q2 		$890 Sell
5
-16
-76% -$421 ﹤0.01% 7193
2025
Q1 		$19.2K Buy
21
+16
+320% +$506 ﹤0.01% 5393
2024
Q4 		$9.85K Buy
5
+3
+150% +$171 ﹤0.01% 5816
2024
Q3 		$10.6K Hold
2
– – ﹤0.01% 5785
2024
Q2 		$8.22K Hold
2
– – ﹤0.01% 5901
2024
Q1 		$14K Hold
2
– – ﹤0.01% 5559
2023
Q4 		$2.14K Hold
2
– – ﹤0.01% 6521
2023
Q3 		$860 Hold
2
– – ﹤0.01% 6867
2023
Q2 		$1.62K Buy
+2
New +$42 ﹤0.01% 6737

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Osaic Holdings's VKTX Position: Q2 2026 in Review

Osaic Holdings reduced its Viking Therapeutics (VKTX) stake by 8% in Q2 2026, selling an estimated $200K and leaving 70,805 shares worth $2.76M. The position accounts for ﹤0.01% of the portfolio, ranked #2037.

Osaic Holdings first reported a position in VKTX in Q1 2020 and has held it in 26 quarters since. 436 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Osaic Holdings held 70,805 shares of Viking Therapeutics worth $2.76M as of Q2 2026.
  • Osaic Holdings sold 6,182 Viking Therapeutics shares in Q2 2026, an estimated $200K.
  • Viking Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #2037 holding.
  • Osaic Holdings first reported a position in Viking Therapeutics in Q1 2020 and has held it in 26 quarters since.
  • 436 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.